CONSORTIUM, PARTNERS AND ROLES
The consortium is a diverse group of experts involved in public health, emerging infectious diseases, epidemiology, microbiology, disease surveillance, bioterrorism, health emergency management, defence, security, humanitarian response, risk communication, social media, big data management, software development, data modelling, decision support tools and public health law from across Europe.
Partners have complementary expertise and knowledge facilitating address of all issues raised in the funding call.
Project partners and roles
The consortium is led by National University of Ireland Galway
which has an established reputation for excellence in the areas of information systems, communication technologies and population health. The School of Medicine has expertise in health security and infectious diseases and has an innovative research programme with the College of Informatics and Engineering and Insight Centre for Data Analytics on application of data science to population health policy challenges. The Ryan Institute with expertise in environment and health and considerable experience in the management of large-scale international research programmes is also working on the project.
FoHM provides expertise on public health developments and relevance of public health actions to multiple organisations ranging from industry to governments at the national, European and international levels. It works to identify and highlight public health issues where effective interventions can be made. In the area of pandemic risk management, a number of microbiology and infectious disease research projects are currently being implemented. Examples are development of new diagnostic methods, modelling scenarios for pandemics and developing new methods for surveillance. The Agency has extensive experience in working on grants from both national and international organisations. The department of Monitoring and Evaluation involved in this project is the national contact-point for several EU and International networks for preparedness. It is also actively involved in a number of projects to increase preparedness for bioterrorism both on national and EU level.
FOI have cutting edge expertise in the threat analysis, crisis management, civil protection and CBRN fields with considerable FP7 security experience and close links to Security networks within Europe. FOI is an assignment-based authority under the Ministry of Defence whose core activities are research, method and technology development, as well as studies for the use of defence, security and safety. FOI proposes problem solving based on new knowledge and new technology. The CBRN division has strong in-house expertise in new technologies including bioinformatics and next generation sequencing, decontamination procedures and biological warfare agents. FOI has many international contacts, clients and cooperation partners amongst foreign agencies, research institutes and companies and is involved in a large number of EU-financed research projects.
IGS Strategic Communications Ltd is a company specialising in providing strategic advice to organisations in the fields of global health and global development. For the PANDEM project, IGS is working on the communications research and dissemination components.
IGS provides expertise on advocacy, communications and fundraising to multiple organisations ranging from private companies to multinational organisations, from national to international levels. IGS has a wealth of front-line communications expertise from previous major outbreaks including SARS, H5N1 and H1N1. Directors of the company have a combined total of more than three decades experience in their fields of expertise.
The London School of Hygiene & Tropical Medicine is a world-leading centre for research and postgraduate education in public and global health. Their mission is to improve health and health equity in the UK and worldwide; working in partnership to achieve excellence in public and global health research, education and translation of knowledge into policy and practice. LSHTM research contributes to health policy and practice in the UK and around the world; they are one of the highest-rated research institutions in the UK, with a unique range and depth of expertise integrating laboratory, clinical, population and social sciences. LSHTM was one of the partners in the innovative EC co-funded PHLawFlu project (2007-10) which investigated the extent to which laws across Europe support or constrain pandemic preparedness planning, and whether national differences are likely to constrain control efforts.
UCL have extensive experience in the development of diagnostic technologies for emerging infectious diseases The Centre for Applied Molecular Technologies (CTMA) hosts a joint civilian-military clinical and research staff with multidisciplinary expertise at UCL. It is a biotechnological platform specializing in genetics and molecular genetics as well as acting as CBRN-biological platform for the Belgian Armed Forces. CTMA is a technology transfer driving scientific research unit with expertise in rapid, specific and sensitive detection, identification and monitoring (DIM) of infectious diseases. CTMA projects contribute to improve the mechanisms of Belgian and EU responses and preparedness to biological threats in a CBRN context. UCL personnel have extensive experience in the field during epidemics and have expertise in mobile laboratories for the rapid detection of CBRN threats.
The WHO Regional Office for Europe supports about 900 million people in 53 Member States in the WHO European Region in developing and sustaining their national health policies, health systems and public health programmes; working to identify, prevent and overcome potential threats to health; anticipating future challenges; and advocating public health. Its work is a two-way exchange: gathering best expertise from key partners in national and international institutions, and analysing data and the research results to propose evidence-based public health interventions. The Regional Office is the focal point for the International Health Regulations (2005) for its 53 Member States. It conducts alert and response operations for outbreaks and public health events of potential international concern. Response operations in the field include epidemiological, microbiological and clinical investigations, emergency vaccination campaigns, and disaster preparedness and response.
The seven PANDEM partners are supported by an Advisory Board of leading global experts in public health, emergency management and security. This Board includes key end-users to ensure the consortium addresses the needs of users such as health and security agencies, civil protection units and first responders and interacts with the wider community represented by civil society organisations.